The Native Antigen Company (NAC) has released a highly purified cytomegalovirus (CMV) native antigen, which has been manufactured in response to the in vitro diagnostics (IVD) industry’s requirement for a cost-effective antigen that can demonstrate a high affinity for IgG and IgM. This latest antigen from NAC’s rapidly increasing portfolio also minimises cross-reactivity and lot-to-lot variation.
Epredia was established in July 2019 through the acquisition by PHC Group of the Anatomical Pathology division of Thermo Fisher Scientific. Our name has changed, however as a standalone business our mission remains the same: to improve lives by enhancing cancer diagnostics.
We are powered by the quality brands you know and trust, such as...
10 Union Street, London, SE1 1SZ
2 March, 2026
Online
3-4 March, 2026
Hinxton Hall Conference Centre, Wellcome Genome Campus, Hinxton, CB10 1RQ
9-10 March, 2026
Online
10-11 March, 2026
Henry B. González Convention Center, San Antonio, Texas, USA
21-26 March, 2026
